就業(yè)前進(jìn)行檢測是否有違禁品-檢測試紙

廣州健侖生物科技有限公司

我司同時(shí)有bzo - bar - coc - thc met - - opi - oxy - mdma - cfp - amp - xtc – bat多聯(lián)檢測卡（膠體金法）

我司還提供：登革熱，黃熱病，基肯孔熱，西尼羅河，立次克體，無形體，蜱蟲，恙蟲，錐蟲，利什曼原蟲，RK39, 漢坦病毒，乙腦，森林腦炎，寨卡病毒 ，H7N9 ,流感，霍亂，軍團(tuán)菌，結(jié)核，諾如病毒，輪狀病毒，炭疽，O157，葡萄球菌 ，流行性出血熱，傷寒桿菌，志賀氏菌檢測試劑,！

如需訂購或者了解請以下或

mob： 楊   ：  

Multi DOA Screen Panel are rapid chromatographic immunoassays for the qualitative and simultaneous detection of one to fourteen of the following drugs in a variety of combinations in human urine. The designed cutoff concentrations and direct calibrator for these drugs are as follows:

The DOA Panels are one-step immunoassay in which chemically labeled drugs (drug-protein conjugates) compete for limited antibody binding sites with drugs which may be present in urine. The test device contains membrane strips which are pre-coated with drug-protein conjugates on the test band(s). Each strip, the drug antibody-colloidal gold conjugate pad is placed at one end of the membrane. In the absence of drug in the urine, the solution of the colored antibody-colloidal gold conjugate move along with the sample solution upward chromatographically by capillary action across the membrane to the immobilized drug-protein conjugate zone on the test band region. The colored antibody-gold conjugate then attach to the drug-protein conjugates to form visible lines as the antibody complex with the drug conjugate. Therefore, the formation of the visible precipitant in the test zone occurs when the test urine is negative for the drug. When the drug is present in the urine, the drug/metabolite antigen competes with drug-protein conjugate on the test band region for the limited antibody.  When a sufficient concentration of the drug is present, it will fill the limited antibody binding sites. This will prevent attachment of the colored antibody (drug-protein conjugate)-colloidal gold conjugate to the drug-protein conjugate zone on the test band region. Therefore, absence of the color band on the test region indicates a positive result.

A control band with a different antigen/antibody reaction is added to the immunochromatographic membrane strip at the control region (C) to indicate that the test has performed properly. This control line should always appear regardless of the presence of drug or metabolite. If the control line does not appear the test device should be discarded. 

就業(yè)前進(jìn)行檢測是否有違禁品-檢測試紙

Allow the test device, urine specimen, and/or controls to reach room temperature (15-30oC) prior to t

【檢測結(jié)果示意圖】

INTERPRETATION OF RESULTS

【注意事項(xiàng)】

• 本品僅用于體外診斷，適用于檢測尿液標(biāo)本，用其它標(biāo)本或溶液進(jìn)行檢測可能出現(xiàn)異常結(jié)果。
• 本品為一次性用品。
• 每一份尿樣均應(yīng)使用新的收集容器，以避免尿樣受到污染。
• 可能由于技術(shù)上或步驟上的操作不當(dāng)，及樣本中有干擾物質(zhì)的存在，導(dǎo)致不*或錯誤的檢測結(jié)果。請查閱“產(chǎn)品性能指標(biāo)”項(xiàng)下特異性中列出的可能引起陽性結(jié)果的物質(zhì)。
• 因本品為目視判讀結(jié)果，為保證判讀結(jié)果的正確，請勿在光線昏暗處對結(jié)果進(jìn)行判讀。
• 尿液樣本和所有用過的物品應(yīng)按可能存在潛在的感染性物品處理。

更多產(chǎn)品說明可通過下方的進(jìn)行了解

添加掃一掃二維碼：

【公司名稱】 廣州健侖生物科技有限公司

【 市場部 】       楊永漢

【】 

【騰訊  】

【公司】http://www.jianlun。。ｃｏｍ

【公司地址】 廣州市清華科技園健新基地番禺石樓鎮(zhèn)健啟路63號二期2幢101-103室